Human SLAMF7/CRACC/CD319 Protein, Accession: Q9NQ25
- Overview
- Specifications
- Shipping, Reconstitution & Storage
- Links
Overview
General Description
Recombinant Human SLAMF7/CRACC/CD319 Protein is expressed from HEK293 with hFc tag at the C-terminal.It contains Ser23-Met226.
Biotinylated
Specifications
Target
SLAMF7/CRACC/CD319
Synonyms
CD2 subset 1; CRACC; Novel Ly9; CD319; SLAMF7; CS1; 19A; FOAP-12
Accession
Species
Human
Exact Sequence
Ser23-Met226
Molecular Weight
The protein has a predicted MW of 49.2 kDa. Due to glycosylation, the protein migrates to 68-80 kDa based on Tris-Bis PAGE result.
Activity
Immobilized Human SLAMF7, hFc Tag at 0.5ug/ml (100ul/Well) on the plate. Dose response curve for Biotinylated Anti-SLAMF7 Antibody, hFc Tag with the EC50 7.3ng/ml determined by ELISA. See testing image for detail.
Product Tag
C-hFc
Express System
HEK293
Purity
> 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC
Endotoxin
Less than 1EU per ug by the LAL method.
Shipping, Reconstitution & Storage
Appearance
Lyophilized
Shipping Conditions
Shipped at ambient temperature.
Formulation
Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.
Reconstitution
Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.
Stability & Storage
Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Declaration
This product is branded by ChemWhat and sold through our website and here is the corresponding link ChemWhat Official Website.
This product is sold exclusively through our sales company Watson International Limited (Ltd), and please click the link below for details. (https://www.watson-int.com/), and here is the corresponding link https://www.watson-int.com/Human-SLAMF7/CRACC/CD319-Protein-accession-Q9NQ25/.